Gmt Capital Corp Kiniksa Pharmaceuticals, Ltd. Transaction History

Gmt Capital Corp

  • $2.45 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$14.37 - $19.07 $1.96 Million - $2.6 Million
-136,300 Reduced 28.52%
341,553 $5.99 Million
Q3 2023

Nov 13, 2023
BUY
$13.62 - $20.2 $2.43 Million - $3.61 Million
178,609 Added 59.69%
477,853 $8.3 Million
Q2 2023

Aug 10, 2023
BUY
$10.44 - $16.48 $3.12 Million - $4.93 Million
299,244 New
299,244 $4.21 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Gmt Capital Corp Portfolio

Follow Gmt Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Gmt Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email